General anesthesia for patients with Brugada syndrome. A report of six cases

Canadian Journal of Anesthesia

Volumn 52, Issue 4, 2005, Pages 409-412

  Inamura, Mihoko ^a   Okamoto, Hirotsugu ^a   Kuroiwa, Masayuki ^a   Hoka, Sumio ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AJMALINE; AMIODARONE; ATROPINE; BUPIVACAINE; DIAZEPAM; DISOPYRAMIDE; EPHEDRINE; FENTANYL; FLECAINIDE; ISOFLURANE; ISOPRENALINE; LIDOCAINE; MEXILETINE; MIDAZOLAM; MIVACURIUM; NEOSTIGMINE; NITRIC OXIDE; NORADRENALIN; PILSICAINIDE; PROCAINAMIDE; PROPOFOL; PROPRANOLOL; QUINIDINE; ROCURONIUM; SEVOFLURANE; THIOPENTAL; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; BRADYCARDIA; BRUGADA SYNDROME; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEFIBRILLATION; DISEASE EXACERBATION; DRUG CONTRAINDICATION; ELECTROCARDIOGRAPHY; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; MALE; PATIENT MONITORING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; ST SEGMENT ELEVATION; SYNCOPE; TREATMENT OUTCOME; VAGUS TONE;

EID: 19944378815     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016285     Document Type: Review

References (14)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-6.
2. Alings M, Wilde A. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99: 666-73.
3. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-6.
4. Brugada R, Brugada J, Antzeledvitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101: 510-5.
5. 3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97: 457-60.
6. Sugi Y, Mori M, Ono M, Kurihara Y. Anesthetic management of a patient with Brugada syndrome (Japanese). Masui 2000; 49: 884-6.
7. Lafuente Martin FJ, Pascual Bellosta A, Abengochea Beisty JM, Fraca Cardiel C, Sanchez Tirado JA, Urieta Solanas JA. Brugada syndrome and anesthesia: a case report (Spanish). Rev Esp Anesthesiol Reanim 1998; 45: 301-2.
8. Edge CJ, Blackman DJ, Gupta K, Sainsbury M. General anaesthesia in a patient with Brugada syndrome. Br J Anaesth 2002; 89: 788-91.
9. Wilde A, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome. Consensus report. Study Group on the Molecular Basis of Arrythmias of the European Society of Cardiology. Circulation 2002; 106: 2514-9.
10. Takenaka S, Emori T, Koyama S, Morita H, Fukushima K, Ohe T. Asymptomatic form of Brugada syndrome. PACE 1999; 22: 1261-3.
11. Antzelevitch C. Ion channels and ventricular arrhythmias: cellular and ionic mechanisms underlying the Brugada syndrome. Curr Opin Cardiol 1999; 14: 274-9.
12. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-70.
13. Phillips N, Priestley M, Denniss AR, Uther JB. Brugada-type electrocardiographic pattern induced by epidural bupivacaine. Anesth Analg 2003; 97: 264-7.
14. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11: 1320-9.